Boehringer Ingelheim and Apexigen sign manufacturing agreement
|
06 December 2012 |
Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner's proprietary pipeline
|
12 November 2012 |
Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D
|
01 November 2012 |
The Respimat® success story: Boehringer Ingelheim doubles its production capacity
|
28 October 2012 |
Boehringer Ingelheim congratulates Nobel Prize winner Prof. Brian Kobilka
|
11 October 2012 |
Boehringer Ingelheim launches beta social game Syrum to promote science and innovation
|
16 September 2012 |
Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration
|
07 September 2012 |
Clinical experience with Pradaxa® crosses one million patient-years of treatment
|
27 August 2012 |
Boehringer Ingelheim achieves further growth in first half of 2012
|
14 August 2012 |
Boehringer Ingelheim Biopharmaceuticals announces manufacturing agreement with Servier
|
08 August 2012 |
Boehringer Ingelheim pursuing health care innovation
|
12 July 2012 |
Boehringer Ingelheim establishes translational research collaboration with Harvard University
|
09 July 2012 |
Boehringer Ingelheim expands development capacities with new technical centre
|
31 May 2012 |
One million signatures needed to call upon World Health Organisation
|
22 May 2012 |
Boehringer Ingelheim and Xencor enter a collaboration agreement
|
23 February 2012 |
Boehringer Ingelheim significantly expands its supply center for China
|
26 December 2011 |
Pradaxa® awarded Prix Galien for most innovative product in Canada
|
27 November 2011 |
Thirteen Finalists Chosen for Boehringer Ingelheim and Ashoka Changemakers "Making More Health" Competition
|
13 November 2011 |
Boehringer Ingelheim and Gilead sign license agreement for novel HIV non-catalytic integrase inhibitors
|
07 October 2011 |
Boehringer Ingelheim enrols first patient in TOviTO Phase III clinical trial program
|
23 September 2011 |